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Figure 1. Histochemical (1A-1C) and Immunohistochemical (1D-1F) stainings;
Chondrogenic genes expression of MSCs-hBM cultured in DMEM and Chondron-
genic medium, measured as Relative Expression Levels (R.E.L.) (2A-2C); SEM (3A-
3D) and TEM (3E-3H) images; Total collagen concentration (mg/ 650 ml) measured in
the culture supernatants, supernatants of chondrogenic (4A) and DMEM medium
(4B).
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natants were collected every 3-4 days to determine collagen presence
by Elisa assays.
Results: Hematoxylin-eosin (HE) (ﬁg.1A) and Masson’s trichrome (MT)
(ﬁg.1B) staining showed that stimulated hBM-MSCs spread throughout
the biomaterials in high percentage, showing a good morphology at
both times of study as well as awide distribution of Extracellular Matrix
(ECM). These constructs showed positivity for safranin O (SO) (ﬁg.1C),
Toluidine Blue (TB), aggrecan (Agg) (ﬁg.1D) and type II collagen (Col II)
(ﬁg.1E). Isolated cells were able to proliferate on Col I and various
concentrations of HS scaffolds, as they showed high percentages of
positivity for Proliferating Cell Nuclear Antigen (PCNA) proliferation
marker (ﬁg.1F). hBM-MSCs proliferated better when cultured in chon-
drogenic medium than in the usual growth medium (DMEM 20%
FBS).Degradation of biomaterials was gradual, as ﬁbers were replaced
with ECM. Molecular analysis indicated the expression of cartilage-
characteristic genes, such as Sox9 [SRY (sex determining region Y)-box
9], Agg and Col II (ﬁg.2) and absence of Col I, a marker of hypertrophic
cells. Scanning and transmission electron microscopy conﬁrmed the
presence of cells and ECM after 15 and 30 days of culture. Cells attached
to the scaffolds and exhibited a rounded morphology (ﬁg.3A-3D). They
showed a high number of distended Rough Endoplasmic Reticulum
(R.E.R) cisternae (ﬁg.3E), electrodense and bright vesicles (ﬁg.3F, 3G),
and great amount of mitochondria, suggesting great cell activity. New
ﬁbrils were differentiated surrounding cell surfaces at both times of
study, conforming neosynthesized cartilage (ﬁg.3H). Finally, culture
supernatants analyses showed the release of collagen in most of thetime periods studied (ﬁg.4), conﬁrming the chondrogenic differentia-
tion of the hBM-MSCs.
Conclusions: Col I and HS scaffolds were optimal for hBM-MSCs growth
and also contributed to their phenotype maintenance. Our supports
favour differentiation towards chondrocytes-like cells after both 15 and
30 days in chondrogenic medium. Detection of extracellular matrix
characteristic compounds in the constructs conﬁrms chondrogenic
differentiation and synthesis of cartilaginous tissue, proving their
possible use to regenerate cartilage damages. Acknowledgements: B.
Parma (OPOCRIN S.P.A.); P. Esbrit (Fundación Jiménez Díaz),
CAM(S2009/MAT-1472); CIBER BBN CB06-01-0040; REDICENT.
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Purpose: Osteoarthritis is a degenerative disease characterized by the
degradation of articular cartilage. Human bone marrow mesenchymal
stem cells (BM-MSCs) have been presented as candidate cells for
cartilage repair due to their ability to undergo chondrogenic differen-
tiation after extensive expansion in vitro and stimulation with various
biomaterials in three-dimensional systems. Due to the attractive
properties of poly(L-lactic acid) (PLLA) and chitosan (CHT) scaffolds for
TE, this study is aimed at analyzing the chondrogenic potential of BM-
MSCs derived from OA patients, in PLLA, alone or combined with CHT,
for application in cartilage repair strategies.
Methods: PLLA scaffolds were prepared by a mixed technique of phase
separation and porogen; PLLA-CHT1 and-CHT2 were prepared by ﬁlling
PLLA with a CHT solution (0.5% w/v). For PLLA-CHT1: excess CHT was
removed and scaffolds were quenched in liquid nitrogen; For PLLA-
CHT2: CHT coating was dried at 37o C, for 24h; this was repeated three
times. Then, in both samples, CHT was gelled at -20o C, in a sodium
hydroxide-ethanol solution, during 3 days. Subsequently, samples were
washed in distilled water and freeze-dried. The morphology and
mechanical properties of the scaffolds were analyzed. BM-MSCs,Ă
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scaffolds. Cell-constructs were cultured for 4 and 8 weeks, in a well-
deﬁned chondrogenic differentiation medium. Cellular metabolic
activity was followed using the Alamar Blue assay. Histological
examination was performed using hematoxylin-eosin, toluidine blue
and safranin-O stainings, as well as immunohistochemistry analysis of
types I, II and X collagen.
Results: Gravimetric analysis of the proposed scaffolds indicated
porosities higher than 80%. PLLA presented spherical interconnected
pores; incorporation of -CHT1, revealed a ﬁlling of the PLLA macro-
porous structure, whereas in -CHT2, chitosan appears as a thin coating
on the porewalls. The presence of a more hydrophilic component (CHT)
renders a higher water absorption capability which could be related to
lower mechanical properties, although in this case this is expected to
confer PLLA, normally applied in bone, properties more appropriate to
its application in soft tissues. Cells’ metabolic activity was signiﬁcantly
increased, after 30 days, evidencing the biocompatible character of the
scaffolds. The chondrogenic differentiation was followed, and after 4
weeks, cells secreted an extracellular matrix rich in proteoglycans
(Figure 1), incorporating type II collagen and aggrecan. When
comparing the different scaffolds, we could observe that PLLA and
PLLA-CHT2 enabled the formation of a more stable tissue whilst PLLA-
CHT1 induced a faster chondrogenic differentiation but at the same
time a premature hypertrophy. Although the most noteworthy was the
tissue organization found in the PLLA alone, that resembled the
biomimetic zones of native articular cartilage.
Conclusions: PLLA alone or combined with CHT scaffolds properties
and support for the chondrogenic differentiation and ECM deposition
could be potential indicated for cartilage TE.
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Purpose: Early treatment of localized cartilage lesions is the prerequi-
site for avoiding the onset of progressive cartilage degeneration and
osteoarthritis. One option is the transplantation of cell suspensions of
autologous chondrocytes (ACT) at defect sites which has proved to
efﬁciently support reconstitution of joint functionality. Nevertheless,
this technique has somewell-known drawbacks like the risks of leakage
of cells from the implantation site or transplant hypertrophy as well as
calciﬁcation and delamination due to the deployment of the perios-
teum. Many of those disadvantages can be circumvented by using
autologous chondrocytes embedded and, hence, immobilized in
matrices (matrix-coupled ACT). The goal of this work is to determine
and establish biomolecular parameters accounting for the quality of
collagen I-matrices seeded with autologous chondrocytes from a local
biotech company. A special focus is set on cartilage-constituting,
matrix-degrading, and cell surface proteins since they might inﬂuence
the clinical outcome after implantation.
Methods: To characterize the chondrocytes in the transplants we detect
chondrocytes- or differentiation speciﬁc markers (e.g., Aggrecan,
Collagen 1A1, 2A1, 2AB, MMP 3, 13, Sox5, Sox6 and Sox9 by means of
quantitative Real-Time-PCR (qPCR). To conﬁrm the results of the (qPCR)
we concentrate on surface markers to detect the chondrogenic capacity
of the chondrocytes in the transplant by means of ﬂow cytometry (FACS).
There are well known surface markers like CD44 and CD90 which are
expressed signiﬁcantly higher in chondrocytes with a higher chondro-
genic capacity. The amount of sulphated glycosaminoglycans (sGAG)
correlates with the chondrocyte-speciﬁc expression of proteoglycans like
aggrecan. In order to evaluate the chondrocytic phenotype and therefore
the presence of the second dominant component of cartilage, we deter-
mined the amount of sGAG in transplants of different patients.
Results: Our results conﬁrm the chondrocytic phenotype of matrix-
embedded cells in collagen I transplants with respect to sGAG synthesis,
gene products and CD markers. We, however, observed pronounced
inter-individual differences in terms of amount of sGAG and gene
products as well as the proliferation of the chondrocytes.
Conclusions: The biomolecular data permit the identiﬁcation of quality
determining parameters which can be used as a quality control of
transplants and the chondrocytes in the collagen I matrix.605
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Purpose: An important feature of biomaterials for cartilage regenera-
tion is their inﬂuence on establishment and stabilization of a chon-
drocytic phenotype of embedded cells. For this biomaterials have to
feature good biocompatibility, biodegradability and allow proper cell
adhesion. In this study we examined the effects of a porous three-
dimensional scaffold of cross-linked hyaluronic acid on the expression
and synthesis performance of human osteoarthritic chondrocytes.
Methods: Human articular cartilage was obtained from osteoarthritic
patients subjected to total knee arthroplasty. Cells were isolated from
cartilage tissue, expanded until passage 2 and seeded onto the scaffold.
This was followed by a three week cultivation period. Cell content
within the scaffold was estimated by determination of the metabolic
activity (XTT assay) and quantiﬁcation of DNA (CyQuant cell prolifera-
tion assay). The expressions of chondrocyte-speciﬁc genes as well as the
synthesis of sulphated glycosaminoglycans (sGAG) by embedded cells
were analyzed in order to characterize the synthesis performance and
differentiation status of the cells. Also electron and light microscope
images on different time points were made.
Results: Within the scaffold, cells are arranged individually or in small
cell clusters and the distribution was homogenous. Although DNA
quantiﬁcation indicated only partial loss of cells most probably due to
matrix degradation, the metabolic activity within the scaffolds decreased
dramatically. This might be attributed to a stop in cell proliferation
combinedwith a switch of the cellular genetic program from cell division
to differentiation towards a chondrogenic phenotype. Analysis of gene
expression and sGAG synthesis substantiated this hypothesis as both
chondrocyte speciﬁc gene expression and sGAG synthesis were increased
and the differentiation index was clearly improved.
Conclusions: These results suggest that the investigated material has
a chondroinductive effect on embedded cells.Ă
